Prevalence of treatable depression is as high as 25% among terminally ill patients. The incidence of antidepressant use was ascertained at the Mayo Hospice Program in Rochester, Minnesota, from June 1, 2007, to December 31, 2008. The 18-month cumulative probability to receive an antidepressant during hospice was estimated at 11.7%. Depression and selective serotonin reuptake inhibitors (SSRIs) were the most common clinical indication and class of antidepressant, respectively. Survival was the main predictor to receive an antidepressant with an odds ratio of 2.71 (95%CI: 1.60-4.60) for each additional day in hospice. Proper diagnostic tools for this population, education about the benefits of antidepressants in palliative care, and clear guidelines about antidepressant class and dosages are needed.
Hotopf M., Chidgey J., Addington-Hall J., Ly KLDepression in advanced disease: a systematic review Part 1. Prevalence and case finding. Palliat Med. 2002;16(2):81-97.
2.
Grassi L., Indelli M., Marzola M., et al. Depressive symptoms and quality of life in home-care-assisted cancer patients. J Pain Symptom Manage. 1996 ;12(5):300-307.
3.
Chochinov HM , Wilson KG, Enns M., et al. Desire for death in the terminally ill. Am J Psychiatry. 1995;152(8):1185-1191.
4.
Breitbart W. , Rosenfeld BD, Passik SDInterest in physician-assisted suicide among ambulatory HIV-infected patients. Am J Psychiatry. 1996;153(2):238-242.
5.
Back AL, Starks H., Hsu C., Gordon JR, Bharucha A., Pearlman RAClinician-patient interactions about requests for physician-assisted suicide: a patient and family view. Arch Intern Med. 2002;162(11):1257-1265.
6.
Henriksson MM , Isometsa ET, Hietanen PS, Aro HM, Lonnqvist JKMental disorders in cancer suicides. J Affect Disord. 1995;36(1-2):11-20.
7.
Cassileth BR , Lusk EJ, Strouse TB, Miller DS, Brown LL, Cross PAA psychological analysis of cancer patients and their next-of-kin. Cancer. 1985;55(1):72-76.
8.
Schulz R., Beach SRCaregiving as a risk factor for mortality: the caregiver health effects study . JAMA. 1999;282(23):2215-2219.
9.
Fisch MJ, Loehrer PJ, Kristeller J., et al. Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group. J Clin Oncol. 2003;21(10):1937-1943.
10.
Qaseem A., Snow V., Shekelle P., et al. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008;148(2): 141-146.
11.
Miller KE, Adams SM, Miller MMAntidepressant medication use in palliative care. Am J Hosp Palliat Care. 2006;23(2):127-133.
12.
Goldberg RJ, Mor V.A survey of psychotropic use in terminal cancer patients. Psychosomatics. 1985;26(9):745-748, 751.
13.
Lloyd-Williams M., Friedman T., Rudd N.A survey of antidepressant prescribing in the terminally ill. Palliat Med. 1999;13(3): 243-248.
14.
Rabkin J., McElhiney M., Moran P., Acree M., Folkman S.Depression, distress and positive mood in late-stage cancer: a longitudinal study. Psychooncology. 2009;18(1):79-86.
15.
Melvin TA, Ozbek IN, Eberle DERecognition of depression. Hosp J. 1995;10(3):39-46.
16.
Lorenz KA, Lynn J., Dy SM, et al. Evidence for improving palliative care at the end of life: a systematic review. Ann Intern Med. 2008;148(2):147-159.
17.
Shimizu K., Akechi T., Shimamoto M., et al. Can psychiatric intervention improve major depression in very near end-of-life cancer patients? Palliat Support Care. 2007;5(1):3-9.
18.
Kugaya A., Akechi T., Nakano T., Okamura H., Shima Y., Uchitomi Y.Successful antidepressant treatment for five terminally ill cancer patients with major depression, suicidal ideation and a desire for death. Support Care Cancer. 1999;7(6):432-436.
19.
Holland JC, Romano SJ, Heiligenstein JH, Tepner RG, Wilson MGA controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psychooncology. 1998;7(4):291-300.
20.
Razavi D., Allilaire JF, Smith M., et al. The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatr Scand. 1996;94(3):205-210.
21.
Costa D., Mogos I., Toma T.Efficacy and safety of mianserin in the treatment of depression of women with cancer. Acta Psychiatr Scand Suppl. 1985;320:85-92.
22.
Braun UK, Kunik ME, Pham C.Treating depression in terminally ill patients can optimize their physical comfort at the end of life and provide them the opportunity to confront and prepare for death. Geriatrics. 2008;63(6):25-27.
23.
Lander M., Wilson K., Chochinov HMDepression and the dying older patient. Clin Geriatr Med. 2000;16(2):335-356.
24.
Brunelli C. , Costantini M., Di Giulio P., et al. Quality-of-life evaluation: when do terminal cancer patients and health-care providers agree? J Pain Symptom Manage. 1998;15(3):151-158.
Chochinov HM , Wilson KG, Enns M., Lander S. "Are you depressed?’’ Screening for depression in the terminally ill. Am J Psychiatry. 1997;154(5):674-676.
27.
Lloyd-Williams M., Dennis M., Taylor F., Baker I.Is asking patients in palliative care, ‘‘are you depressed?’’ Appropriate? Prospective study. BMJ. 2003;327(7411):372-373.
28.
Hinton J.Which patients with terminal cancer are admitted from home care? Palliat Med. 1994;8(3):197-210.
29.
Maguire P. Barriersto psychological care of the dying. Br Med J (Clin Res Ed). 1985;291(6510):1711-1713.
30.
Lawrie I., Lloyd-Williams M., Taylor F.How do palliative medicine physicians assess and manage depression. Palliat Med. 2004;18(3):234-238.
31.
Block SDPerspectives on care at the close of life. Psychological considerations, growth, and transcendence at the end of life: the art of the possible. JAMA. 2001;285(22):2898-2905.
32.
Irwin SA, Rao S., Bower K., et al. Psychiatric issues in palliative care: recognition of depression in patients enrolled in hospice care. J Palliat Med. 2008;11(2):158-163.
33.
Fox E., Landrum-McNiff K., Zhong Z., Dawson NV, Wu AW, Lynn J.Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments . JAMA. 1999; 282(17):1638-1645.
34.
Chochinov HM , Wilson KG, Enns M., Lander S.Prevalence of depression in the terminally ill: effects of diagnostic criteria and symptom threshold judgments. Am J Psychiatry. 1994;151(4): 537-540.
35.
Lloyd-Williams M., Shiels C., Taylor F., Dennis M.Depression-an independent predictor of early death in patients with advanced cancer. J Affect Disord.2009;113(1-2):127-132.
36.
Candy M., Jones L., Williams R., Tookman A., King M.Psychostimulants for depression. Cochrane Database Syst Rev.2008(2): CD006722-CD006722.
37.
Satel SL, Nelson JCStimulants in the treatment of depression: a critical overview. J Clin Psychiatry. 1989;50(7):241-249.
